Evidence map›Paper›PMID 21211645›Full record

ReviewThe Journal of allergy and clinical immunology2011

Advances in pediatric asthma in 2010: addressing the major issues.

Stanley J Szefler

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. PACE: Pharmacists use the power of communication in paediatric asthma.International journal of clinical pharmacy · 2014
    Article
  4. Article
  5. Article
  6. Review
  7. Magnesium concentration in acute asthmatic children.Iranian journal of pediatrics · 2012
    Article
  8. Development of a novel tool for engaging children and parents in asthma self-management.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2012
    Article
  9. Advancing asthma care: the glass is only half full!The Journal of allergy and clinical immunology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Stanley J SzeflerDivision of Pediatric Clinical Pharmacology, Department of Pediatrics, National Jewish Health, Denver, Colo. 80206, USA. szeflers@njhealth.org
National Jewish Health · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
EARLY INTERVENTION IN CHILDHOOD ASTHMAU10HL064288 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 1999 to 2008
$6.7M
LABORATORY COREU01HL081335 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ACCURSO, FRANK J. · 2005 to 2008
$4.1M
STEROID AND TARGET CELL FOCUS IN THE TREATMENT OF ASTHMAU10HL051834 · NHLBI · NATIONAL JEWISH HEALTH · PI MARTIN, RICHARD J · 1993 to 2002
$2.3M
CAMP Contiunation Study/Phase 3U01HL075416 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 2003 to 2010
$1.4M
Progression of Airway Obstruction in Childhood AsthmaR21HL087811 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 2008 to 2009
$429k
CLINICAL CENTER FOR CAMPN01HR016048 · HR · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J · 1991 to 2000
$0k
Inner-City Asthma Consortium-266025496-266025496N01AI025496 · NIAID · UNIVERSITY OF WISCONSIN · PI BUSSE, WILLIAM · 2002 to 2006
–
NCRR NIH HHS 1 UL1 RR025780NCRR NIH HHS UL1 RR025780NHLBI NIH HHS HL075416NHLBI NIH HHS HL081335NHLBI NIH HHS HL51834NHLBI NIH HHS HL64288NHLBI NIH HHS HR-16048NHLBI NIH HHS N01 HR016048NHLBI NIH HHS R21 HL087811NHLBI NIH HHS U01 HL075416NHLBI NIH HHS U01 HL081335NHLBI NIH HHS U10 HL051834NHLBI NIH HHS U10 HL064288NIAID NIH HHS N01 AI025496
6 · The paper itself

Abstract

Last year's "Advances in pediatric asthma" concluded with the following statement: "If we can close these [remaining] gaps through better communication, improvements in the health care system and new insights into treatment, we will move closer to better methods to intervene early in the course of the disease and induce clinical remission as quickly as possible in most children." This year's summary will focus on recent advances in pediatric asthma that take steps moving forward as reported in Journal of Allergy and Clinical Immunology publications in 2010. Some of these recent reports show us how to improve asthma management through steps to better understand the natural history of asthma, individualize asthma care, reduce asthma exacerbations, and manage inner-city asthma and some potential new ways to use available medications to improve asthma control. It is clear that we have made many significant gains in managing asthma in children, but we have a ways to go to prevent asthma exacerbations, alter the natural history of the disease, and reduce health disparities in asthma care. Perhaps new directions in personalized medicine and improved health care access and communication will help maintain steady progress in alleviating the burden of this disease in children, especially young children.

Indexed as

AsthmaChildHealthcare DisparitiesHealth Services AccessibilityHumansPediatricsPrecision Medicine

Identifiers

PMID21211645
PMCPMC3032272
OpenAlexW2087573097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.